Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYTouchREVIEWS in endocrinology

Clinical outcomes of tirzepatide in a real-world follow-up cohort of patients with type 2 diabetes

  • Thein M Tun1
  • Muhammad Sabir1
  • Hasanain Alismael1
  • Alice Gatenby1
  • Theint T Su1
  • Lucy Walters2
  • Timothy Green3
  • Stephen C Bain3
  • Richard Chudleigh3
  • Rajesh Peter2
  • Jeffrey W Stephens1
  • Thinzar Min2
  1. 1Diabetes Department, Morriston Hospital, Swansea Bay UHB, Swansea, UK
  2. 2Diabetes Department, Neath Port Talbot Hospital, Swansea Bay UHB, Swansea, UK
  3. 3Diabetes Department, Singleton Hospital, Swansea Bay UHB, Swansea, UK
Read full textPDFDOICite

Related

  1. Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters
    Hiroya Kitsunai, Fumika Maruyama, Yukie Miyano +9
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGEDOAJ
  2. Effects of Metformin on Clinical Outcomes After Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Ting-Yen Chen, Yu-Chi Su, Yu-Ching Lin
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Utilisation Patterns and Clinical Outcomes of Teleconsultation Versus Face‐to‐Face Follow‐Up of Breast Cancer Patients in the Post‐COVID‐19 Era
    Hilda Wong, Timothy Robinson, Thomas Strawson-Smith +3
    International Journal of Breast CancerPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  4. Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes.
    Hideyuki Okuma
    Diabetology internationalPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMC
  5. Tirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study
    Wan-Hsuan Hsu, Yang-En Chan, Jheng-Yan Wu +5
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{tun2026clinical,
  title = {{Clinical outcomes of tirzepatide in a real-world follow-up cohort of patients with type 2 diabetes}},
  author = {Thein M Tun and Muhammad Sabir and Hasanain Alismael and Alice Gatenby and Theint T Su and Lucy Walters and Timothy Green and Stephen C Bain and Richard Chudleigh and Rajesh Peter and Jeffrey W Stephens and Thinzar Min},
  journal = {TouchREVIEWS in endocrinology},
  year = {2026},
  month = jul,
  doi = {10.17925/ee.2026.22.2.1},
  url = {https://europepmc.org/article/PMC/PMC13730170},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Clinical outcomes of tirzepatide in a real-world follow-up cohort of patients with type 2 diabetes
AU  - Thein M Tun
AU  - Muhammad Sabir
AU  - Hasanain Alismael
AU  - Alice Gatenby
AU  - Theint T Su
AU  - Lucy Walters
AU  - Timothy Green
AU  - Stephen C Bain
AU  - Richard Chudleigh
AU  - Rajesh Peter
AU  - Jeffrey W Stephens
AU  - Thinzar Min
PY  - 2026
DA  - 2026/07/02
JO  - TouchREVIEWS in endocrinology
DO  - 10.17925/ee.2026.22.2.1
UR  - https://europepmc.org/article/PMC/PMC13730170
SN  - 2752-5457
ER  -